TP53 and non-Hodgkin lymphoma: Of particular interest are TP53-mutated lymphoid malignancies (i.e. non-Hodgkin lymphoma and chronic lymphocytic leukemia), which lack the recurrent copy number losses observed in TP53-mutated myeloid malignancies.